Clinical Trial Update: Intravenous Fosfomycin Pharmacokinetics Study [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of intravenous fosfomycin completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Multiple-drug Resistance

Drugs mentioned

• Fosfomycin (Fosfomycin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacterial Infection, Multiple-drug Resistance | Phase 1 | Status: COMPLETED | Results posted: 2022-01-19